These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8554795)

  • 1. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valproate induced parkinsonism].
    Park-Matsumoto YC; Tazawa T
    No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic functions in epileptics on sodium valproate monotherapy.
    Jha S; Agarwal DK; Shukla S; Nag D; Saxena RC
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):305-6. PubMed ID: 8550134
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reversible dementia due to valproic acid therapy].
    Walstra GJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):391-3. PubMed ID: 9157301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spasmodic dysphonia induced by valproic acid.
    Oh J; Park KD; Cho HJ; Choi KG; Jung SM
    Epilepsia; 2004 Jul; 45(7):880-1. PubMed ID: 15230719
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium valproate in the management of intractable epilepsy: comparison with clonazepam.
    Lance JW; Anthony M
    Proc Aust Assoc Neurol; 1975; 12():55-60. PubMed ID: 814547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible parkinsonism induced by prolonged treatment with valproate].
    Barroso B
    Therapie; 2002; 57(4):410-1. PubMed ID: 12422564
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced Parkinsonism in epilepsy patients.
    Jamora D; Lim SH; Pan A; Tan L; Tan EK
    Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the toxicity of valproic-acid.
    Moreiras Plaza M; Rodríguez Goyanes G; Cuiña L; Alonso R
    Clin Nephrol; 1999 Mar; 51(3):187-9. PubMed ID: 10099893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edema associated with valproate therapy.
    Basel-Vanagaite L; Zeharia A; Amir J; Mimouni M
    Ann Pharmacother; 1999 Dec; 33(12):1370-1. PubMed ID: 10630841
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parkinsonism due to the medication].
    Louter M; Tromp SC
    Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transient Parkinson syndrome and tremor caused by the use of sodium valproate].
    van der Zwan A
    Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1230-2. PubMed ID: 2501690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Encephalopathies caused by valproate].
    Göbel R; Görtzen A; Bräunig P
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dementia and extrapyramidal problems caused by long-term valproic acid].
    Masmoudi K; Gras-Champel V; Bonnet I; Pannier M; Masson H; Rosa A; Andréjak M
    Therapie; 2000; 55(5):629-34. PubMed ID: 11201978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stupor associated with the treatment of epilepsy with valproate].
    Skjødt T; Sørensen T
    Ugeskr Laeger; 1984 Apr; 146(15):1137-8. PubMed ID: 6429914
    [No Abstract]   [Full Text] [Related]  

  • 18. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
    Ristić AJ; Vojvodić N; Janković S; Sindelić A; Sokić D
    Epilepsia; 2006 Dec; 47(12):2183-5. PubMed ID: 17201721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of valproate on bone mineral density.
    Gilles P; Alliët P; Bruneel E; Raes M
    J Pediatr; 1996 Mar; 128(3):441. PubMed ID: 8774525
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G; Marková J; Mastík J
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.